Latest News about NBIX
Recent news which mentions NBIX
From InvestorPlace
From Benzinga
Breaking Down Neurocrine Biosciences: 8 Analysts Share Their Views
February 08, 2024
Tickers
NBIX
From Benzinga
Earnings Scheduled For February 7, 2024
February 07, 2024
From Benzinga
From InvestorPlace
3 Stocks at the Forefront of Medical Innovation
December 25, 2023
From InvestorPlace
The 3 Most Undervalued Biotech Stocks to Buy in December
December 15, 2023
From InvestorPlace
Analyst Expectations for Neurocrine Biosciences's Future
December 07, 2023
Tickers
NBIX
From Benzinga
Why Is Neurocrine Biosciences Stock Trading Lower Today?
November 10, 2023
From Benzinga
Neurocrine Biosciences shares drop as trial failures may ‘stunt momentum,’ analysts say
November 10, 2023
From MarketWatch
3 Biotech Moonshots to Bet on the Future of Health
November 06, 2023
From InvestorPlace
Raymond James Maintains Outperform Rating for Neurocrine Biosciences: Here's What You Need To Know
November 01, 2023
Tickers
NBIX
From Benzinga
What 22 Analyst Ratings Have To Say About Neurocrine Biosciences
October 06, 2023
Tickers
NBIX
From Benzinga
Why Is Neurocrine Biosciences Shares Trading Higher Today?
October 05, 2023
Tickers
NBIX
From Benzinga
Analyst Expectations for Neurocrine Biosciences's Future
September 13, 2023
Tickers
NBIX
From Benzinga
From Benzinga
What's Going On With Neurocrine Biosciences Stock Today?
September 12, 2023
Tickers
NBIX
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
From Benzinga
FDA Greenlights Expanded Use Of Neurocrine Biosciences' Ingrezza: Analysts Weigh In Depression Warning
August 21, 2023
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.